Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50

GWAS Microarray

By Drug Discovery Trends Editor | March 15, 2010

Illumina, Inc. offers the HumanOmniExpress BeadChip (OmniExpress) microarray for genome-wide association studies (GWAS). Designed as a 12-sample Beadchip, OmniExpress allows interrogation of over 700,000 variants per sample totaling more than eight million available data points on a single chip. Coupled with the Illumina iScan System, OmniExpress enables processing of more than 1,400 samples per week, the highest throughput in the industry.

The markers on OmniExpress are a subset of the content powering Illumina’s flagship GWAS product, the HumanOmni1-Quad, and incorporate an optimized set of SNPs chosen from all three phases of the International HapMap Project. As with the HumanOmni1, researchers starting with OmniExpress can take advantage of future supplemental Omni BeadChips containing new content derived from the 1000 Genomes Project.

The OmniExpress BeadChip supports copy number variation (CNV) analyses for disease-association studies and is compatible with Illumina’s automation solutions. First customer shipments of the OmniExpress are expected in the first quarter of 2010.

Illumina 


Filed Under: Drug Discovery

 

Related Articles Read More >

Takeda Pharmaceutical in the Drug Discovery & Development Pharma 50
Takeda’s Takhzyro fares well in pediatric hereditary angioedema study
Novartis in the Pharma 50
Novartis to cut up to 8,000 positions
Gilead Sciences in the Drug Discovery & Development Pharma 50
Gilead resubmits application to FDA for twice-yearly HIV drug lenacapavir
George Floyd mural
How the pandemic and George Floyd made clinical trial diversity a priority

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Drug Discovery news in a minute?

We Deliver!
Drug Discovery & Development Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Drug Discovery and Development
  • MASSDEVICE
  • DEVICETALKS
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • MEDTECH 100
  • Medical Design Sourcing
  • Subscribe to our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50